Article
Differential Genetic and Morphofunctional Patterns of Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients with Pre-existing Hypertension
2026-05-19
Abstract excerpt
<title>Abstract</title> <p> Background. Current HFA-ICOS guidelines do not mandate intensive monitoring for patients at low or moderate risk. However, pre-existing arterial hypertension (AH) before chemotherapy (CTx) may qualitatively alter myocardial sensitivity to anthracyclines, necessitating the classification of these patients into a distinct surveillance group. Objective. To conduct a comparative analysi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a63a3331-543e-5935-9cee-59e49c809a4b
- DOI
- 10.21203/rs.3.rs-9616662/v1
